AMF Tjänstepension’s Alexion Pharmaceuticals ALXN Stock Holding History

AMF Tjänstepension’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-282,644	Closed	-$34.3M	–	203
2017 Q2	$34.3M	Hold	282,644	–	–	0.39%	101
2017 Q1	$34.3M	Buy	282,644 +238	+0.1%	+$30.7K	0.39%	101
2016 Q4	$34.6M	Buy	282,406 +244,306	+641%	+$29.9M	0.4%	91
2016 Q3	$4.67M	Sell	38,100 -800	-2%	-$103K	0.06%	170
2016 Q2	$4.54M	Buy	38,900 +1,000	+3%	+$142K	0.06%	158
2016 Q1	$5.28M	Sell	37,900 -1,850	-5%	-$272K	0.07%	145
2015 Q4	$7.58M	Buy	39,750 +26,500	+200%	+$4.63M	0.11%	134
2015 Q3	$2.07M	Hold	13,250	–	–	0.03%	187
2015 Q2	$2.4M	Buy	13,250 +3,150	+31%	+$544K	0.03%	187
2015 Q1	$1.75M	Buy	10,100 +250	+3%	+$45.3K	0.02%	192
2014 Q4	$1.82M	Buy	+9,850	New	+$1.83M	0.02%	194

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AMF Tjänstepension's ALXN Position: Q3 2017 in Review

AMF Tjänstepension sold out of Alexion Pharmaceuticals (ALXN) in Q3 2017, closing a stake of 282,644 shares — an estimated $34.3M sold.

AMF Tjänstepension first reported a position in ALXN in Q4 2014 and held it in 11 quarters. The position peaked at $34.6M in Q4 2016. 595 funds tracked by Wall St. Rank hold ALXN as of Q3 2017.

AMF Tjänstepension reported no remaining Alexion Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
AMF Tjänstepension sold 282,644 Alexion Pharmaceuticals shares in Q3 2017, an estimated $34.3M.
AMF Tjänstepension first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 11 quarters.
AMF Tjänstepension's Alexion Pharmaceuticals position peaked at $34.6M in Q4 2016.
595 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2017.

Based on AMF Tjänstepension's 13F filing for Q3 2017, filed 8 Nov 2017.